Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005936

CEO and Chairman sold 30,000 shares at an average $59.38 ($1,781,546)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-26 Sale : show line 1 in the form −3,850 $62.51 $240,664 1,765,930 D
2021-01-26 Sale : show line 2 in the form −2,524 $63.63 $160,602 1,763,406 D
2021-01-26 Sale : show line 3 in the form −3,526 $64.52 $227,498 1,759,880 D
2021-01-26 Sale : show line 4 in the form −100 $65.23 $6,523 1,759,780 D
2021-01-27 Sale : show line 5 in the form −1,879 $54.63 $102,650 1,757,901 D
2021-01-27 Sale : show line 6 in the form −1,000 $56.26 $56,260 1,756,901 D
2021-01-27 Sale : show line 7 in the form −2,000 $57.71 $115,420 1,754,901 D
2021-01-27 Sale : show line 8 in the form −3,246 $58.79 $190,832 1,751,655 D
Open-market sales · 30,000 sh · avg $59.38 · $1,781,546
Loading xslF345X03/doc4.xml…